Newsroom
February 9, 2022
Treatment could aim to raise levels of a neuroprotective molecule, studies hint. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Feb. 9, 2022) — Growing evidence suggests that traumatic brain injury (TBI) is an important risk factor for developing Alzheimer’s disease and dementia. But to date, effective therapies aren’t available for preventing or treating TBI-induced […]
December 20, 2021
Mice missing one copy of the Tbx1 gene exhibit slower cognitive processing. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 20, 2021) — Myelin, a sheath of insulation around nerves that enables electrical impulses to efficiently travel through the central nervous system, is diminished in mice that have a gene deletion associated with autism […]
December 17, 2021
Emerging evidence suggests it may be possible to treat Alzheimer’s disease by targeting therapy at senescent cells in the brain.
December 17, 2021
Chemical’s release in brain tied to processing of imagery, cells’ activation. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 17, 2021) — “Look at me!” we might say while attempting to engage our children. It turns out there is a neurochemical explanation for why looking at mom or dad actually helps kiddos pay better […]
November 8, 2021
Radiation that at first is beneficial later causes cells to senesce, promoting brain cancer’s return. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Nov. 8, 2021) — It’s a medical conundrum. Ionizing radiation, which at first extends the survival of glioblastoma patients after surgery, may later, ironically, help drive the brain cancer’s aggressive, untreatable recurrence. […]
October 19, 2021
Dr. James Lechleiter, Cell Systems and Anatomy, is quoted in this KENS 5 story. Watch story